Neurocrine Biosciences, Inc. <NBIX.O>: Wells Fargo raises target price to $200 from $175
NBIX•Related News
Walker & Dunlop Investment Partners closes USD 241.8 million multifamily bridge loans in Q2 2026
WD•
Prescott Group Capital Management reports $2.31 million Nature's Sunshine Products common share buy
NATR•
HubSpot director Gerald Dischler acquires $199,735.25 in common shares
HUBS•
Alignment Healthcare CEO John Kao disposes of 298,000 common shares worth $4.14 million
ALHC•
NIQ to host Client Academy webinar on European shopper trends
NIQ•